CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.010
-0.040 (-3.81%)
Nov 4, 2024, 4:00 PM EST - Market closed
CytomX Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$5.77
Upside
+471.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 27, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $2.25 → $3.5 | Hold → Buy | Upgrades | $2.25 → $3.5 | +246.53% | May 28, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $3.25 → $3.59 | Hold | Maintains | $3.25 → $3.59 | +255.45% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 9, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades $3 → $8 | Hold → Buy | Upgrades | $3 → $8 | +692.08% | May 9, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2.5 → $8 | Hold → Strong Buy | Upgrades | $2.5 → $8 | +692.08% | May 6, 2024 |
| BMO Capital | BMO Capital | Hold Reiterates $3.25 | Hold | Reiterates | $3.25 | +221.78% | May 1, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Apr 22, 2024 |
| Wedbush | Wedbush | Hold Reiterates $3 | Hold | Reiterates | $3 | +197.03% | Mar 12, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $3.3 → $3.25 | Hold | Maintains | $3.3 → $3.25 | +221.78% | Mar 12, 2024 |
| Wedbush | Wedbush | Hold Maintains $2 → $3 | Hold | Maintains | $2 → $3 | +197.03% | Nov 9, 2023 |
| Wedbush | Wedbush | Hold → Buy Upgrades $2 → $3 | Hold → Buy | Upgrades | $2 → $3 | +197.03% | Nov 8, 2023 |
| BMO Capital | BMO Capital | Hold Maintains $3.15 → $3.19 | Hold | Maintains | $3.15 → $3.19 | +215.84% | Aug 9, 2023 |
| Mizuho | Mizuho | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +98.02% | Mar 28, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.